Rothschild Investment LLC’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-16,450
| Closed | -$160K | – | 386 |
|
2018
Q2 | $160K | Sell |
16,450
-2,170
| -12% | -$21.1K | 0.02% | 358 |
|
2018
Q1 | $162K | Sell |
18,620
-9,850
| -35% | -$85.7K | 0.02% | 360 |
|
2017
Q4 | $356K | Hold |
28,470
| – | – | 0.04% | 311 |
|
2017
Q3 | $238K | Sell |
28,470
-28,600
| -50% | -$239K | 0.03% | 366 |
|
2017
Q2 | $968K | Buy |
57,070
+11,450
| +25% | +$194K | 0.11% | 205 |
|
2017
Q1 | $917K | Buy |
45,620
+22,225
| +95% | +$447K | 0.11% | 205 |
|
2016
Q4 | $365K | Buy |
+23,395
| New | +$365K | 0.04% | 314 |
|